Table 3.
Respiratory-related evoked potential waveform components mean latency and amplitude data
| RREP Latencies at Cz, ms |
RREP Latencies at Pz, ms |
|||
|---|---|---|---|---|
| Controls | OSA | Controls | OSA | |
| P1 | 25 ± 1 | 25 ± 2 | 28 ± 2 | 29 ± 2 |
| N1 | 46 ± 4 | 44 ± 2 | 46 ± 4 | 44 ± 2 |
| P2 | 82 ± 5 | 88 ± 4 | 81 ± 4 | 89 ± 6 |
| N2 | 121 ± 3 | 138 ± 3* | 123 ± 3 | 140 ± 3* |
| P3 | 218 ± 15 | 225 ± 7 | 221 ± 16 | 230 ± 9 |
| RREP Amplitudes at Cz, μV |
RREP Amplitudes at Pz, μV |
|||
|---|---|---|---|---|
| Controls | OSA | Controls | OSA | |
| P1 | 4 ± 1 | 4 ± 1 | 5 ± 1 | 4 ± 1 |
| N1 | −9 ± 2 | −8 ± 1 | −4 ± 1 | −5 ± 1 |
| P2 | 10 ± 2 | 13 ± 2 | 11 ± 2 | 10 ± 1 |
| N2 | −9 ± 2 | −8 ± 3 | −6 ± 2 | −6 ± 2 |
| P3 | 21 ± 2 | 23 ± 3 | 17 ± 1 | 20 ± 2 |
Values are means ± SE.
*
Significant difference in the respiratory-related evoked potential (RREP) waveform component in the OSA patients compared with controls.